发明授权
- 专利标题： Pyrimidine derivatives that inhibit FAK/PTK2
- 专利标题（中）： 抑制FAK / PTK2的嘧啶衍生物
-
申请号： US14049575申请日： 2013-10-09
-
公开(公告)号： US08785464B2公开(公告)日： 2014-07-22
- 发明人: Heinz Stadtmueller , Bodo Betzemeier , Ioannis Sapountzis
- 申请人： Heinz Stadtmueller , Bodo Betzemeier , Ioannis Sapountzis
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Alan R. Stempel
- 优先权： EP08169805 20081124
- 主分类号： C07D401/12
- IPC分类号： C07D401/12 ; C07D401/14 ; A61K31/505
摘要：
The present invention includes compounds of general formula (1) wherein A, X, R1 and R2 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
公开/授权文献
- US20140038993A1 NEW COMPOUNDS 公开/授权日：2014-02-06
信息查询
